References
- 1. M. Wesoły, K. Cal, P. Ciosek and W. Wróblewski, Influence of dissolution-modifying excipients in various pharmaceutical formulations on electronic tongue results, Talanta162 (2017) 203–209; https://doi.org/10.1016/j.talanta.2016.10.018
- 2. A. Nokhodchi, C. M. Hentzschel and C. S. Leopold, Drug release from liquisolid systems: speed it up, slow it down, Expert Opin. Drug Deliv.8 (2011) 191–205; https://doi.org/10.1517/17425247.2011.548801
- 3. L. Azharshekoufeh, J. Shokri, M. B. Jalali and Y. Javadzadeh, Liquigroud technique: a new concept for enhancing dissolution rate of glibenclamide by combination of liquisolid and co-grinding technologies, BioImpacts7 (2017) 5–12; https://doi.org/10.15171/bi.2017.02
- 4. A. B. Karmarkar, I. D. Gonjar and A. H. Hosmani, Liquisolid technology for dissolution rate enhancement or sustained release, Expert Opin. Drug Deliv.7 (2010) 1227–1234; https://doi.org/10.1517/17425247.2010.511173
- 5. I. Theochari, M. Goulielmaki, D. Danino, V. Papadimitriou, A. Pintzas and A. Xenakis, Drug nanocarriers for cancer chemotherapy based on microemulsions: the case of Vemurafenib analog PLX4720, Colloids Surf. B Biointerfaces154 (2017) 350–356; https://doi.org/10.1016/j.colsurfb.2017.03.032
- 6. M. Colombo, S. Staufenbiel, E. Rühl and R. Bodmeier, In situ determination of the saturation solubility of nanocrystals of poorly soluble drugs for dermal application, Int. J. Pharm.521 (2017) 156–166; https://doi.org/10.1016/j.ijpharm.2017.02.030
- 7. K. Sigfridsson, P. Skantze, U. Skantze, L. Svensson, L. Löfgren, P. Nordell, E. Michaëlsson, B. Smedsrød, B. Fuglesteg and K. Elvevold, Nanocrystal formulations of a poorly soluble drug. 2. Evaluation of nanocrystal liver uptake and distribution after intravenous administration to mice, Int. J. Pharm.524 (2017) 248–256; https://doi.org/10.1016/j.ijpharm.2017.03.062
- 8. R. Ghanavati, A. Taheri and A. Homayouni, Anomalous dissolution behavior of celecoxib in PVP/Isomalt solid dispersions prepared using spray drier, Mater. Sci. Eng. C72 (2017) 501–511; https://doi.org/10.1016/j.msec.2016.11.042
- 9. K. I. Shingel, M. Selyanin, M. C. Filion and F. Polyak, Solid dispersions of drugs in hyaluronan matrix: The role of the biopolymer in modulating drug activity in vivo, J. Drug Deliv. Sci. Technol.39 (2017) 140–146; https://doi.org/10.1016/j.jddst.2017.03.018
- 10. P. Veres, M. Kéri, I. Bányai, I. Lázár, I. Fábián, C. Domingo and J. Kalmár, Mechanism of drug release from silica-gelatin aerogel. Relationship between matrix structure and release kinetics, Colloids Surf. B Biointerfaces152 (2017) 229–237; https://doi.org/10.1016/j.colsurfb.2017.01.019
- 11. M. Lu, H. Xing, T. Yang, J. Yu, Z. Yang, Y. Sun and P. Ding, Dissolution enhancement of tadalafil by liquisolid technique, Pharm. Dev. Technol.22 (2017) 77–89; https://doi.org/10.1080/10837450.2016.1189563
- 12. K. T. Savjani, A. K. Gajjar, J and K. Savjani, Drug solubility: Importance and enhancement techniques, ISRN Pharm.2012 (2012) 1–10; https://doi.org/10.5402/2012/195727
- 13. T. L. Rogers, K. A. Overhoff, P. Shah, P. Santiago, M. J. Yacaman, K. P. Johnston and R. O. Williams, Micronized powders of a poorly water soluble drug produced by a spray-freezing into liquid-emulsion process, Eur. J. Pharm. Biopharm.55 (2003) 161–172; https://doi.org/10.1016/S0939-6411(02)00193-5
- 14. Y. Javadzadeh, B. Jafari-Navimipour and A. Nokhodchi, Liquisolid technique for dissolution rate enhancement of a high dose water-insoluble drug (carbamazepine), Int. J. Pharm.341 (2007) 26–34; https://doi.org/10.1016/j.ijpharm.2007.03.034
- 15. Y. Javadzadeh, M. R. Siahi, S. Asnaashari and A. Nokhodchi, Liquisolid technique as a tool for the enhancement of poorly water-soluble drugs and evaluation of their physicochemical properties, Acta Pharm.57 (2007) 99–109; https://doi.org/10.2478/v10007-007-0008-6
- 16. Y. Javadzadeh, M. Siahi-Shadbad, M. Barzegar-Jalali and A. Nokhodchi, Enhancement of dissolution rate of piroxicam using liquisolid compacts, Il Farmaco60 (2005) 361–365; https://doi.org/10.1016/j.farmac.2004.09.005
- 17. V. De Campos, C. Cerqueira-Coutinho, F. Capella, B. Soares, C. Holandino and C. Mansur, Development and in vitro assessment of nanoemulsion for delivery of ketoconazole against Candida albicans, J. Nanosci. Nanotechnol.17 (2017) 4623–4630; https://doi.org/10.1166/jnn.2017.13445
- 18. P. Deng, F. Teng, F. Zhou, Z. Song, N. Meng and R. Feng, Methoxy poly (ethylene glycol)-b-poly (δ-valerolactone) copolymeric micelles for improved skin delivery of ketoconazole, J. Biomater. Sci. Polym. Ed.28 (2017) 63–78; https://doi.org/10.1080/09205063.2016.1244371
- 19. G. A. Abdelbary, M. M. Amin and M. Y. Zakaria, Ocular ketoconazole-loaded proniosomal gels: formulation, ex vivo corneal permeation and in vivo studies, Drug Deliv.24 (2017) 309–319; https://doi.org/10.1080/10717544.2016.1247928
- 20. A. M. Stewart, M. E. Grass, D. M. Mudie, M. M. Morgen, D. T. Friesen and D. T. Vodak, Development of a biorelevant, material-sparing membrane flux test for rapid screening of bioavailability-enhancing drug product formulations, Mol. Pharm.14 (2017) 2032–2046; https://doi.org/10.1021/acs.molpharmaceut.7b00121
- 21. J. Bassi da Silva, S. B. d. S. Ferreira, O. de Freitas and M. L. Bruschi, A critical review about methodologies for the analysis of mucoadhesive properties of drug delivery systems, Drug Dev. Ind. Pharm.43 (2017) 1053–1070; https://doi.org/10.1080/03639045.2017.1294600
- 22. A. Ruff, T. Fiolka and E. S. Kostewicz, Prediction of Ketoconazole absorption using an updated in vitro transfer model coupled to physiologically based pharmacokinetic modelling, Eur. J. Pharm. Sci.100 (2017) 42–55; https://doi.org/10.1016/j.ejps.2016.12.017
- 23. Y. Tsume, K. Matsui, A. L. Searls, S. Takeuchi, G. E. Amidon, D. Sun and G. L. Amidon, The impact of supersaturation level for oral absorption of BCS class IIb drugs, dipyridamole and ketoconazole, using in vivo predictive dissolution system: Gastrointestinal Simulator (GIS), Eur. J. Pharm. Sci.102 (2017) 126–139; https://doi.org/10.1016/j.ejps.2017.02.042
- 24. T. Loftsson and E. Stefánsson, Cyclodextrins and topical drug delivery to the anterior and posterior segments of the eye, Int. J. Pharm.531 (2017) 413–423; https://doi.org/10.1016/j.ijpharm.2017.04.010
- 25. G. Balata, M. Mahdi and R. A. Bakera, Improvement of solubility and dissolution properties of ketoconazole by solid dispersions and inclusion complexes, Indian J. Pharm. Sci.5 (2011) 517–526; https://doi.org/10.4103/0250-474X.98995
- 26. K. Inaba, T. Wakuda and K. Uekama, Prostaglandins and their cyclodextrin complexes, J. Incl. Phenom. Macrocycl. Chem.2 (1984) 467–474; https://doi.org/10.1007/BF00662213
- 27. P. Kanaujia, G. Lau, W. K. Ng, E. Widjaja, M. Schreyer, A. Hanefeld, M. Fischbach, C. Saal, M. Maio and R. B. Tan, Investigating the effect of moisture protection on solid-state stability and dissolution of fenofibrate and ketoconazole solid dispersions using PXRD, HSDSC and Raman microscopy, Drug Dev. Ind. Pharm.37 (2011) 1026–1035; https://doi.org/10.3109/03639045.2011.558091
- 28. A. Gryczke, S. Schminke, M. Maniruzzaman, J. Beck and D. Douroumis, Development and evaluation of orally disintegrating tablets (ODTs) containing Ibuprofen granules prepared by hot melt extrusion, Colloids Surf. B Biointerfaces.86 (2011) 275–284; https://doi.org/10.1016/j.colsurfb.2011.04.007
- 29. M. Dhanaraju, K. S. Kumaran, T. Baskaran and M. S. R. Moorthy, Enhancement of bioavailability of griseofulvin by its complexation with β-cyclodextrin, Drug Dev. Ind. Pharm.24 (1998) 583–587; https://doi.org/10.3109/03639049809085663
- 30. Y. Javadzadeh, M. R. Siahi, S. Asnaashari and A. Nokhodchi, An investigation of physicochemical properties of piroxicam liquisolid compacts, Pharm. Dev. Technol.12 (2007) 337–343; https://doi.org/10.1080/10837450701247574